Discuss the First Amendment defense to off-label promotion claims. Do you agree that companies should be permitted to share truthful, non-misleading information with customers?Why? How, if at all, should the First Amendment aspect of off-label promotion influence the compliance programs that companies implement?How should the government distinguish between truthful, non-misleading speech and false and misleading claims when evaluating a company's promotion of a drug or medical device?